Dlk Investment Management, LLC Editas Medicine, Inc. Transaction History
Dlk Investment Management, LLC
- $239 Billion
- Q4 2024
A detailed history of Dlk Investment Management, LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Dlk Investment Management, LLC holds 25,719 shares of EDIT stock, worth $37,549. This represents 0.01% of its overall portfolio holdings.
Number of Shares
25,719
Previous 19,202
33.94%
Holding current value
$37,549
Previous $65.5 Million
50.12%
% of portfolio
0.01%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding EDIT
# of Institutions
227Shares Held
54.2MCall Options Held
412KPut Options Held
355K-
Black Rock Inc. New York, NY7.78MShares$11.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.82MShares$9.96 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.75MShares$4.01 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.16MShares$3.15 Million0.0% of portfolio
-
State Street Corp Boston, MA1.87MShares$2.73 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $100M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...